Pulling the memo together.
Fetching live price, fundamentals, analyst consensus, and news.
Fetching live price, fundamentals, analyst consensus, and news.
Hold rating, composite score 6/10 at $374.58 (-11.89 (-3.08%)). Full scorecard, fundamentals, technicals, sentiment, risks, and catalysts below — or look up a different ticker.
| Dimension | Score | Key Signal |
|---|---|---|
| Fundamentals | 6/10 | modest revenue growth (+8% YoY); clean balance sheet (D/E 0.10) |
| Technicals | 5/10 | below 200-day |
| Sentiment / News | 6/10 | 27 of 54 analysts bullish — strong consensus buy |
| Composite | 6/10 | Rating: Hold |
Tesla Inc (Automobiles) trades at $374.58 with a market capitalization of $1.48T.
Revenue grew +8.3% year-over-year on a trailing basis. Trailing net profit margin sits at 3.1%. At a trailing P/E of 459.8, the market is pricing in substantial future growth. The balance sheet carries a debt-to-equity ratio of 0.10 — a notably clean capital structure.
The 52-week range spans $297.38 to $498.83. Current price sits -24.9% from the high and +26% from the low — well below its recent peak.
The moving-average structure is mixed (50-day $363.12, 200-day $386.64). No clean trend signal here; the tape is in transition. The 14-day RSI at 52.8 is in neutral territory. MACD histogram is positive at +0.06, confirming bullish short-term momentum.
Performance: 30-day return +3.0%, 90-day -8.9%, 1-year -15.4%. Maximum drawdown over the trailing year reached -39.1%. Annualized volatility sits at 45.5% — elevated but not extreme, typical of growth names.
As of 2026-10-01, 54 analysts cover TSLA: 10 Strong Buy, 17 Buy, 22 Hold, 5 Sell, 0 Strong Sell. The consensus leans positive but is not unanimous. Bullish coverage has contracted versus the prior month — worth watching.
The most recent earnings (2026-09-30) beat expectations: actual EPS of $0.48 versus consensus of $0.44 (+0.04 surprise). A 10.1% positive surprise.
The composite rating of Hold (6/10) reflects a middling setup without clear conviction signals. Thesis breaks if analyst revisions turn sharply negative or earnings execution falters.